A resolution recognizing the 50th anniversary of the development of the Salk polio vaccine and its importance in eradicating the incidence of polio.

(This measure has not been amended since it was introduced. The summary of that version is repeated here.)

Recognizes the achievements of Dr. Jonas Salk and his team of researchers at the University of Pittsburgh in developing the Salk polio vaccine on the 50th anniversary of its approval and use.

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 101 Agreed to Senate (ATS)]







109th CONGRESS
  1st Session
S. RES. 101

 Recognizing the 50th anniversary of the development of the Salk polio 
   vaccine and its importance in eradicating the incidence of polio.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             April 6, 2005

 Mr. Santorum (for himself, Mr. Specter, and Mr. Lautenberg) submitted 
      the following resolution; which was considered and agreed to

_______________________________________________________________________

                               RESOLUTION


 
 Recognizing the 50th anniversary of the development of the Salk polio 
   vaccine and its importance in eradicating the incidence of polio.

Whereas the epidemic of polio struck the citizens of the United States in the 
        early 1950s, causing thousands of cases of lingering paralysis and 
        death;
Whereas the epidemic of polio peaked in 1952, having affected nearly 58,000 
        people, mainly children and young adults;
Whereas many of those affected by polio needed the assistance of mechanical 
        ventilators in order to breathe, while others were crippled and 
        dependent upon crutches for mobility;
Whereas University of Pittsburgh faculty member Dr. Jonas Salk and his team of 
        researchers developed the first vaccine against polio;
Whereas, in April 1955, the results of an unprecedented and successful 
        nationwide clinical trial of the polio vaccine were announced; and
Whereas the Salk polio vaccine was approved for widespread public use at that 
        time: Now, therefore, be it
    Resolved, That the Senate--
            (1) recognizes the pioneering achievement of Dr. Jonas Salk 
        and his team of researchers at the University of Pittsburgh in 
        the development of the Salk polio vaccine;
            (2) expresses its appreciation to--
                    (A) the family of Dr. Salk for the elimination of 
                polio, a disease that caused countless deaths and 
                disabling consequences;
                    (B) the members of Dr. Salk's research team; and
                    (C) the individuals who generously agreed to 
                participate in clinical trials to validate the efficacy 
                of the polio vaccine; and
            (3) celebrates with the University of Pittsburgh on the 
        50th anniversary of the approval and use of the Salk polio 
        vaccine.
                                 <all>